Free preview

Chronic Myelogenous Leukemia (CML)

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Chronic myeloid leukemia (CML) begins when a blood-forming stem cell acquires a chromosome change. The change creates an enzyme that keeps signaling cells to grow. The marrow makes excess white cells, and people may notice fatigue or fullness from an enlarged spleen, or have no symptoms. Targeted medicines block the abnormal signal, and blood tests track the leukemia even after blood counts return to normal.

Clinical Definition

CML is a myeloproliferative neoplasm driven by an acquired BCR::ABL1 fusion, usually from t(9;22)(q34;q11.2). The shortened derivative chromosome 22 is the Philadelphia chromosome. Its constitutively active kinase, typically p210, expands a hematopoietic stem-cell clone while preserving granulocyte maturation in chronic phase. A left-shifted granulocytosis, basophilia and splenomegaly are classic clues. Effective tyrosine kinase inhibition can sustain chronic-phase control for many years.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses